Acquiring Company
Webster Equity Partners
Acquired Company
Lifecore Biomedical
Description
Webster Equity Partners is acquiring Lifecore Biomedical, Inc. for $6.28 per share in cash. This acquisition also includes one non-tradable contingent value right per share. The transaction is part of a series of proposed mergers and acquisitions under investigation for potential shareholder rights violations.
Quick answer
Webster Equity Partners is acquiring Lifecore Biomedical, announced September 29, 2026. Webster Equity Partners is based in New York, New York, United States.
- How much did Webster Equity Partners pay for Lifecore Biomedical?
- The deal value was not disclosed.
- What does Webster Equity Partners do?
- Webster Equity Partners is a private equity firm focused on investing in and acquiring companies across various sectors.
- Where are Webster Equity Partners and Lifecore Biomedical based?
- Webster Equity Partners is based in New York, New York, United States. Lifecore Biomedical is based in Chaska, Minnesota, United States.
- Who are the decision-makers at Webster Equity Partners?
- Fundz holds 2 contacts at Webster Equity Partners. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who to call at Webster Equity Partners, and when
When Webster Equity Partners changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Webster Equity Partners raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Webster Equity Partners, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Webster Equity Partners. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Webster Equity Partners makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Lifecore Biomedical?
Lifecore Biomedical was acquired by Webster Equity Partners, based in New York. The deal was reported on September 29, 2026. Webster Equity Partners is a private equity firm focused on investing in and acquiring companies across various sectors. It seeks to enhance value by leveraging its industry expertise and management capabilities. Webster Equity Partners is privately held and operates in Financial Services.
When did Webster Equity Partners acquire Lifecore Biomedical?
Webster Equity Partners's acquisition of Lifecore Biomedical was reported on September 29, 2026. Webster Equity Partners is acquiring Lifecore Biomedical, Inc. for $6.28 per share in cash. This acquisition also includes one non-tradable contingent value right per share. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Lifecore Biomedical do?
Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO) focused on injectable fill/finish capabilities for the pharmaceutical industry. It is publicly traded (LFCR), operating in Other, and is based in Chaska.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.